News – Page 1047 – Endpoints News

Gilead R&D chief Norbert Bischofberger is leaving in surprise exit, CEO revamps top science jobs

8 years ago

AstraZeneca pushes back OS readout on MYSTIC to H2; Anthera shares obliterated in repeat PhIII flop

8 years ago

Busy Sanofi takes a pass on one of Alnylam’s rare disease drugs, FDA offers ‘breakthrough’ status for PhIII

8 years ago

Sarepta plays nice with the FDA, sets out plans for second accelerated Duchenne pitch by year's end

8 years ago

Biogen is hustling a schizophrenia drug into PhIIb after Pfizer lets it go in $590M CNS fire sale

8 years ago

Regeneron boosted, rival Esperion slammed as investors scramble to catch up to a PCSK9 price war

8 years ago

Bitter board members at Arcturus head to legal office to vote on directors

8 years ago

With debt looming, browbeaten diet pill maker Orexigen goes bankrupt -- shares slide

8 years ago

Operations head Wyss exits Novartis, giving way to new structure and a string of promotions

8 years ago

Praluent Odyssey: Regeneron/Sanofi gun for market breakout with first-ever mortality benefit — and a big price ...

8 years ago

Martin Shkreli sentenced to 7 years on felony fraud convictions

8 years ago

Outsourcing veteran Jamie Macdonald takes the helm at Parexel; CSO Rosana Kapeller exits Nimbus

8 years ago

Hua Medicine plans to join trendy Hong Kong IPO club, pitching an offering of up to $400M -- reports

8 years ago

The Martin Shkreli saga ends today, but the issue he raised on drug pricing seems immortal

8 years ago

Senators heap abuse on Allergan's attempt at an end run around patent reviews, offer bill to stop 'sham'

8 years ago

Voyager's gene therapy for Parkinson's shows promise in early data from small Phase Ib trial

8 years ago

In wake of Eli Lilly setback, Merck KGaA's leading BTK drug for autoimmune disease clears PhIIb hurdle

8 years ago

Xeris hauls $55M in new funding to bring glucagon pen to market

8 years ago

MyoKardia steps closer to the launch of a groundbreaking heart trial after finding its low-dose starting point

8 years ago

Nimbus founding CSO Rosana Kapeller leaves to explore exec role; AI startup BioXcel pockets $60M from IPO

8 years ago

Juno, WuXi JV gets a $90M round as China’s CAR-T pioneers fly high with fresh cash

8 years ago

Failure in pivotal PhIII brain cancer trial drags Israel's VBL Therapeutics down

8 years ago

Bound for the clinic with a new approach to synthetic lethality, Cyteir bags $29M

8 years ago

Prevail grabs $75M A round in the hunt for new gene therapies to stop the destruction caused by Parkinson's

8 years ago

First page Previous page 1044 1045 104610471048 1049 1050 Next page Last page